欧米茄-3多不和脂肪酸通过GPR120抑制脏亡,缓解高尿血性脏病
Zhi Yang1, Hao Li1, Hong-Yan Wu1
1Department of Nephrology, West China Hospital, Sichuan University, Guoxue Alley 37#, Chengdu 610041, Sichuan, PR China.
Biochemical pharmacology
|October 13, 2024
概括
欧米茄-3脂肪酸,如DHA和EPA,减少脏炎症和改善功能在高尿素性脏病. 它们通过通过GPR120激活和NLRP3炎症酶通路来抑制热.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 高尿素性脏病 (HN) 涉及由于高尿酸的脏炎症.
- 欧米茄-3多不和脂肪酸 (PUFA) 具有抗炎性质,但它们在HN中的作用尚不清楚.
研究的目的:
- 研究omega-3PUFAs (DHA和EPA) 对高尿素性脏病的治疗作用.
- 阐明在HN中欧米茄-3PUFA的保护作用背后的分子机制.
主要方法:
- 使用腺素和氧酸盐建立了HN的小鼠模型.
- 小鼠接受了四周的DHA,EPA或其组合治疗.
- 进行了转录组测序,G蛋白结合受体120 (GPR120) 抗剂/抗剂治疗,并进行了共免疫沉试验.
主要成果:
- 在HN小鼠中,欧米茄-3PUFAs显著降低了血清尿酸,并改善了功能.
- DHA和EPA治疗有效降低了炎标记物,包括NLRP3,裂开的气体皮质-D,-1和IL-1β.
- DHA的保护作用部分由GPR120激活介导,导致NLRP3炎症酶抑制.
结论:
- 欧米茄-3 PUFA 在高尿素性病中显示出显著的保护作用.
- 抗炎机制涉及NLRP3 / caspase-1 / GSDMD热致死途径的调节,部分通过GPR120激活.
- DHA和EPA代表了管理HN脏炎症的潜在治疗剂.
相关概念视频
Antihypertensive Drugs: Action of Diuretics
625
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
625
Renal Drug Excretion: Tubular Secretion
147
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
147
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


